Co-immunization with two recombinant Eimeria tenella lines expressing immunoprotective antigens of E. maxima elicits enhanced protection against E. maxima infection. 2019

Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing, China.

BACKGROUND Live anticoccidial vaccines have been a tremendous success for disease prevention. The establishment of the reverse genetic manipulation platform has enabled the development of Eimeria parasites, the live anticoccidial vaccine strains, as vaccine vectors. In our previous study, recombinant E. tenella expressing a single immunodominant antigen of E. maxima (Et-EmIMP1) was able to protect chickens against challenge infection with E. maxima. This promising result encouraged us to further explore strategies to improve the protection efficacy of recombinant Eimeria and develop it as a vaccine vector. RESULTS We constructed a novel recombinant Eimeria line expressing apical membrane antigen 1 of E. maxima (Et-EmAMA1) and then immunized chickens with Et-EmAMA1 and/or Et-EmIMP1. We found that the E. maxima soluble antigen-specific cell-mediated immunity was much stronger in the birds that were co-immunized with Et-EmAMA1 and Et-EmIMP1 than in those that were immunized with Et-EmAMA1 or Et-EmIMP1 alone. The oocyst production after E. maxima infection was significantly reduced in the recombinant Eimeria-immunized birds compared with the wild-type-immunized and naïve birds. The oocyst production in the birds co-immunized with Et-EmAMA1 and Et-EmIMP1 was consistently the lowest among the treatment groups after E. maxima infection. CONCLUSIONS These results demonstrated that Eimeria is an effective vaccine vector that can carry and deliver heterologous Eimeria antigens to the host immune system and trigger specific immune responses. Our results also suggested that increasing the number of recombinant Eimeria lines is an effective approach to enhance protective immunity against infections with heterologous pathogens.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D011201 Poultry Diseases Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild. Disease, Poultry,Diseases, Poultry,Poultry Disease
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D003048 Coccidiosis Protozoan infection found in animals and man. It is caused by several different genera of COCCIDIA. Besnoitiasis,Besnoitiosis,Besnoitiases,Besnoitioses,Coccidioses
D004539 Eimeria A genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals. Eimerias
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D013047 Specific Pathogen-Free Organisms Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free. Pathogen-Free Organisms,Specific Pathogen Free,Organism, Pathogen-Free,Organism, Specific Pathogen-Free,Organisms, Pathogen-Free,Organisms, Specific Pathogen-Free,Pathogen Free Organisms,Pathogen Free, Specific,Pathogen Frees, Specific,Pathogen-Free Organism,Pathogen-Free Organism, Specific,Pathogen-Free Organisms, Specific,Specific Pathogen Free Organisms,Specific Pathogen-Free Organism
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
July 2020, Parasites & vectors,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
August 2017, Veterinary parasitology,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
December 2022, Veterinary parasitology,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
September 2015, Parasitology research,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
January 2017, Frontiers in immunology,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
January 2021, Frontiers in veterinary science,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
February 2004, Veterinary parasitology,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
October 1993, Veterinary immunology and immunopathology,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
March 2015, Avian diseases,
Xinming Tang, and Chaoyue Wang, and Lin Liang, and Dandan Hu, and Sixin Zhang, and Chunhui Duan, and Jingxia Suo, and Xianyong Liu, and Xun Suo, and Shangjin Cui
November 2013, Parasitology research,
Copied contents to your clipboard!